Biosynex (XPAR:ALBIO) Capital Expenditure : €-4.84 Mil (TTM As of Dec. 2024)

View and export this data going back to 2011. Start your Free Trial

What is Biosynex Capital Expenditure?

Cash flow for capital expenditures refers to the funds spent for a company to acquire or upgrade physical assets such as property, industrial buildings or equipment.

Biosynex's cash flow for capital expenditures for the six months ended in Dec. 2024 was €-2.8 Mil. Its cash flow for capital expenditures for the trailing twelve months (TTM) ended in Dec. 2024 was €-4.84 Mil.

Biosynex Capital Expenditure Historical Data

The historical data trend for Biosynex's Capital Expenditure can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Biosynex Capital Expenditure Chart

Biosynex Annual Data

Trend

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Dec24

Capital Expenditure

Get a 7-Day Free Trial

-9.12

-19.02

-37.77

-39.54

-4.84

Biosynex Semi-Annual Data
	Jun15	Dec15	Jun16	Dec16	Jun17	Dec17	Jun18	Dec18	Jun19	Dec19	Jun20	Dec20	Jun21	Dec21	Jun22	Dec22	Jun23	Dec23	Jun24	Dec24
Capital Expenditure	Get a 7-Day Free Trial															-18.56	-31.97	-7.58	-2.07	-2.77

Biosynex Capital Expenditure Calculation

Cash flow for capital expenditures refers to the funds spent for a company to acquire or upgrade physical assets such as property, industrial buildings or equipment.

Capital Expenditure for the trailing twelve months (TTM) ended in Dec. 2024 adds up the semi-annually data reported by the company within the most recent 12 months, which was €-4.84 Mil.

Biosynex Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Biosynex SA (XPAR:ALBIO) » Definitions » Capital Expenditure

Comparable Companies

Traded in Other Exchanges

N/A

Address

22 Boulevard Sebastien Brant, Illkirch, FRA, 67400

Website

http://www.biosynex.com

Biosynex SA is engaged in the research, development, and manufacturing of fast diagnosis tests on membrane support for health professionals. It manufactures and markets medical devices for screening, diagnosis.

Biosynex Headlines

No Headlines